<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0910234318
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        TOBRADEX EYE DROPS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        TOBRAMYCIN,DEXAMETHASONE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.3,0.1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Ocular use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Eye drops, suspension
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Dropper Container
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        21
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="S.A. Alcon Couvreur N.V" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            S.A. Alcon Couvreur N.V
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 439]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Novartis Saudi Limited
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            NOVARTIS PHARMA AG
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        S01CA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>TOBRADEX</strong> contains dexamethasone a corticosteroid and tobramycin, an antibiotic which is active against a wide range of bacteria that may infect the eye.</p><p>&nbsp;</p><p><strong>It is used to prevent and treat inflammation</strong> and prevent possible infection of the eye after cataract surgery in adults and children aged 2 years and older.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><p><strong>a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>Do not use </strong><strong>TOBRADEX...</strong></p><p><strong>&nbsp;</strong></p><p>&bull; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have or think that you have any type of <strong>infection of the eye.</strong> Use of corticosteroids may make infections worse.</p><p>&bull; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have a <strong>sticky discharge</strong> from your eye.</p><p>&bull; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have a <strong>red eye</strong> that has not been seen by a doctor.</p><p>&bull; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are <strong>allergic</strong> to tobramycin or dexamethasone or to any of the other ingredients listed in section 6.</p><p>&nbsp;</p><p>If any of these apply ask your doctor for advice.</p><p>&nbsp;</p><p><strong>b.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>Take special care with Tobradex</strong></p><p><strong>&nbsp;</strong></p><p>&bull; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have a disorder causing a <strong>thinning of the eye tissues,</strong> such as <strong>rheumatoid arthritis,</strong> <strong>Fuch&rsquo;s dystrophy</strong> or following a <strong>corneal transplant</strong>. Corticosteroids may cause further thinning and possible perforation, and may delay the healing of your eye wound. Topical non-steroidal anti-inflammatory drugs (NSAIDs) are also known to slow or delay healing. If you use topical NSAIDS and corticosteroids together, it may increase the potential for healing problems.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you experience allergic reactions with TOBRADEX, discontinue use and consult your doctor. Allergic reactions may vary from localized itching or skin redness to severe allergic reactions (anaphylactic reaction) or serious skin reactions. &nbsp;These allergic reactions may occur with other topical or systemic antibiotics of the same family (aminoglycoside type).</p><p>&bull; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If your symptoms get worse or suddenly return, please consult your doctor. You may become more susceptible to eye infections with the use of this product.</p><p>&bull; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are diabetic please consult your doctor. The risk of corticosteroid-induced increase intraocular pressure and / or cataract formation is increased in diabetic patients.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contact your doctor if you experience blurred vision or other visual disturbances.</p><p>&bull; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are using other antibiotic treatment, including oral, with TOBRADEX, ask your doctor for advice.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have or if you have ever had conditions such as myasthenia gravis or Parkinson&rsquo;s disease, ask your doctor for advice. Antibiotics of this kind may worsen muscle weakness</p><p>&bull; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you use TOBRADEX for a long period of time, you may become more susceptible to eye infections, have increased pressure in your eye(s) or develop cataracts.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Talk to your doctor if you experience swelling and weight gain around the trunk and in the face as these are usually the first manifestations of a syndrome called Cushing&rsquo;s syndrome. Suppression of the adrenal gland function may develop after stopping a long-term or intensive treatment with TOBRADEX. Talk to your doctor before stopping the treatment by yourself. These risks are especially important in children and patients treated with a drug called ritonavir or cobicistat.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Signs and symptoms of adrenal suppression include fatigue; light-headedness upon standing or difficulty standing, muscle weakness, fever, weight loss, anxiety, nausea, vomiting, diarrhoea, headache, sweating, changes in mood or personality, and joint and muscle pains.</p><p>&nbsp;</p><p>You may still be able to use TOBRADEX, but <strong>discuss it with your doctor</strong> first.</p><p>&bull; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Intraocular pressure should be checked frequently, this is especially important in children below 6 years of age receiving dexamethasone-containing products.</p><p>&bull; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not give TOBRADEX to children below 2 years old because the safety and efficacy in this population has not been established.</p><p>&nbsp;</p><p><strong>c.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>Using other medicines, herbal or dietary supplements </strong></p><p>Please <strong>tell your doctor or pharmacist</strong> if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.</p><p>&nbsp;</p><p>Especially tell your doctor if you are using topical NSAIDs. If you use topical steroids and topical NSAIDs together, it may increase corneal healing problems. Tell your doctor if you are using ritonavir or cobicistat, as this may increase the amount of dexamethasone in the blood.</p><p>&nbsp;</p><p>If you are using <strong>other eye drops or eye ointments, wait at least 5 minutes</strong> between using each one. Eye ointments should be administered last.</p><p>&nbsp;</p><p><strong>d.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>Pregnancy and breast-feeding</strong></p><p>If you are pregnant or might get pregnant, or if you are breast-feeding a baby, <strong>talk to your doctor</strong> before you use TOBRADEX. TOBRADEX is not recommended during pregnancy or breastfeeding.</p><p>&nbsp;</p><p><strong>e.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>Driving and using machines</strong></p><p>If you experience temporary blurred vision after using TOBRADEX you should not drive or operate machinery until your vision is clear.</p><p>&nbsp;</p><p><strong>f.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>Important information if you wear Contact Lenses</strong></p><p>Contact lens wear is not recommended during treatment of an ocular infection or inflammation. Benzalkonium chloride, used as a preservative in TOBRADEX, may cause eye irritation and discolour soft <strong>contact lenses.</strong></p><p>If you wear soft <strong>contact lenses</strong> remove them before using TOBRADEX and <strong>wait at least 15 minutes</strong> before putting them back in.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Only use TOBRADEX for dropping in your eye(s).</p><p>&nbsp;</p><p><strong>The usual dose</strong></p><p>The usual dose is 1 drop in the affected eye(s) every 4 to 6 hours while you are awake. During the initial 48 hours, your doctor may increase the dose to 1 drop every 2 hours.</p><p>&nbsp;</p><p>Do not use for more than <strong>24 days.</strong></p><p>&nbsp;</p><p>TOBRADEX may be used in children 2 years of age and older at the same dose as in adults.</p><p><strong>&nbsp;</strong></p><p><strong>Remove the loose collar</strong> from the cap when the bottle is first opened.</p><p>&nbsp;</p><p>Always use TOBRADEX exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p>&nbsp;</p><p><strong>How to use</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wash your hands before you start.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Shake the bottle well.</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Twist off the bottle cap.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hold the bottle pointing down, between your thumb and fingers.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tilt your head back.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pull down your lower eyelid with a finger, until there is a &lsquo;pocket&rsquo; between the eyelid and your eye. The drop will go in here (picture 1).</p><p><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="Picture_x0020_1" o:spid="_x0000_i1027" type="#_x0000_t75"
 style='width:55.5pt;height:55.5pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/khalian2/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
  o:title=""/>
</v:shape><![endif]--><img width="74" height="74" alt="" vspace="0" hspace="0" border="0" style="width:74px;height:74px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" src="file:///C:/Users/khalian2/AppData/Local/Temp/2/msohtmlclip1/01/clip_image002.jpg" /></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bring the bottle tip close to the eye. Do this in front of a mirror if it helps.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Do not touch your eye or eyelid,</strong> surrounding areas or other surfaces with the dropper. It could infect the drops.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Gently press on the base</strong> of the bottle to release one drop at a time (picture 2).</p><p><!--[if gte vml 1]><v:shape
 id="Picture_x0020_2" o:spid="_x0000_i1026" type="#_x0000_t75" style='width:55.5pt;
 height:55.5pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/khalian2/AppData/Local/Temp/2/msohtmlclip1/01/clip_image003.png"
  o:title=""/>
</v:shape><![endif]--><img width="74" height="74" alt="" vspace="0" hspace="0" border="0" style="width:74px;height:74px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" src="file:///C:/Users/khalian2/AppData/Local/Temp/2/msohtmlclip1/01/clip_image004.jpg" /></p><p>&bull; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Do not squeeze the bottle,</strong> only a gentle press on the bottom is needed.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; After using TOBRADEX, keep the eyelid closed, while simultaneously applying gentle pressure with a finger to the corner of your eye, by the nose for at least 1 minute (picture 3). This helps to limit the amount of medicine that will get into the rest of the body.</p><p><!--[if gte vml 1]><v:shape id="Picture_x0020_3" o:spid="_x0000_s1026"
 type="#_x0000_t75" style='position:absolute;left:0;text-align:left;
 margin-left:306.4pt;margin-top:412.4pt;width:63.35pt;height:55.65pt;z-index:251658240;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:page;
 mso-height-relative:page'>
 <v:imagedata src="file:///C:/Users/khalian2/AppData/Local/Temp/2/msohtmlclip1/01/clip_image005.png"
  o:title=""/>
</v:shape><![endif]--><img width="84" height="74" alt="" vspace="0" hspace="0" border="0" style="width:84px;height:74px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" src="file:///C:/Users/khalian2/AppData/Local/Temp/2/msohtmlclip1/01/clip_image006.gif" />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&bull; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you use drops in both eyes, repeat the steps for your other eye. Put the bottle cap firmly back on immediately after use.</p><p>&bull; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If a drop misses your eye,</strong> try again.</p><p>&bull; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If you forget to take</strong><strong> TOBRADEX</strong><strong>,</strong> do not worry, just take it as soon as possible. <strong>Do not take a double dose to make up.</strong></p><p>&bull; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If you use more </strong><strong>TOBRADEX</strong><strong> than you should</strong> it can be washed out with warm water.</p><p>&nbsp;</p><p><strong>If you have any further questions</strong> on the use of<strong> </strong>TOBRADEX, ask your doctor or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, TOBRADEX can cause side effects, although not everybody gets them.</p><p>The following side effects have been seen with TOBRADEX</p><p>&nbsp;</p><p>If you notice any of the following possible side effects, <strong>stop</strong> using this medicine and seek urgent medical advice immediately:</p><ul><li>itchy rash or hives</li><li>swelling of the face, lips, tongue or other parts of the body</li><li>shortness of breath/wheezing</li><li>severe skin reactions such as blistering which may be accompanied by sore throat, fever or headache</li></ul><p><em>&nbsp;</em></p><p>The following side effects have also occurred with TOBRADEX:</p><p>&nbsp;</p><p><strong>Uncommon side effects</strong></p><p><em>(may affect up to 1 in 100 people)</em></p><p><em>&nbsp;</em></p><p><strong>Effects in the eye:</strong> increased pressure in your eye (s), eye irritation, eye pain, eye itching, watery eyes, eye discomfort.</p><p>&nbsp;</p><p><strong>General side effects:</strong> headache, runny nose, tightness of the throat.</p><p>&nbsp;</p><p><strong>Rare side effects</strong></p><p><em>(may affect up to 1 in 1000 people)</em></p><p><em>&nbsp;</em></p><p><strong>Effects in the eye:</strong> redness, blurred vision, dry eye, eye allergy, eye surface inflammation.</p><p>&nbsp;</p><p><strong>General side effects:</strong> bad taste.</p><p>&nbsp;</p><p><strong>Not known</strong> <em>(frequency cannot be estimated from available data)</em></p><p><em>&nbsp;</em></p><p><strong>Effects in the eye:</strong> increase in pupil size, eyelid redness, eyelid swelling, increased tear production,.</p><p>&nbsp;</p><p><strong>General side effects:</strong> dizziness, nausea, abdominal discomfort, rash, swelling of the face, itching.</p><p>&nbsp;</p><p>Hormone problems: growth of extra body hair (particularly in women), muscle weakness and wasting, purple stretch marks on body skin, increased blood pressure, irregular or missing periods, changes in the levels of protein and calcium in your body, stunted growth in children and teenagers and swelling and weight gain of the body and face (called &lsquo;Cushing&rsquo;s syndrome&#39;) (see section 2, &ldquo;Warnings and precautions&rdquo;).</p><p>&nbsp;</p><p>If TOBRADEX is used for more than 24 days, it may cause you to get an infection and the healing of your wound may also be delayed.</p><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system (see details below). By reporting side effects you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store below 30⁰C</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not refrigerate or freeze</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep the bottle tightly closed.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use the drops after the expiry date which is stated on the bottle and the carton after &lsquo;Exp:&rsquo;. The expiry date refers to the last day of that month.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Stop using the bottle 4 weeks after first opening,</strong> to prevent infections.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines should not be disposed of via waste water or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Do not pass this medicine on to others.</strong> It may harm them even if their symptoms are the same as yours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substances are tobramycin 3 mg/ml and dexamethasone 1 mg/ml.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other ingredients are disodium edetate, tyloxapol, sodium chloride, sodium sulphate, hydroxyethylcellulose, benzalkonium chloride, sulphuric acid and/or sodium hydroxide (to adjust pH) and purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                TOBRADEX is a white to off-white suspension supplied in a pack containing a 5 ml plastic bottle with a screw cap.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The Marketing Authorization Holder for this Product is Novartis Pharma AG.</p><p>www.Novartis.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised by MHRA on: 08/2019
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي عقار <strong>توبرادكس</strong> على ديكساميثازون وهو أحد الكورتيكوستيرويدات وتوبراميسين، وهو مضاد حيوي نشط ضد نطاق واسع من البكتيريا التي قد تصيب العين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>يُستخدم العقار لمنع وعلاج الالتهاب</strong> ومنع احتمالية عدوى العين ما بعد عملية المياه البيضاء (كاتاراكت) في البالغين والأطفال من سن سنتين وأكبر.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;</p><p dir="RTL">أ&zwnj;.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>موانع استعمال عقار توبرادكس:</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني أو تعتقد أنك تعاني من أي نوع من <strong>العدوى في العين</strong>. استخدام الكورتيكوستيرويدات قد يجعل العدوى أسوأ.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك <strong>إفرازات لزجة</strong> يتم إفرازها من عينك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك <strong>احمرار بالعين</strong> لم يفحصه الطبيب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من <strong>حساسية</strong> تجاه توبراميسين أو ديكساميثازون أو أيٍّ من المكونات الأخرى المدرجة في قسم: 6</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا انطبق أي من ذلك، يُرجى استشارة طبيبك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ب&zwnj;.&nbsp;&nbsp;&nbsp;&nbsp; <strong>الاحتياطات عند استعمال عقار توبرادكس</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من اضطراب يُسبب <strong>ترقق أنسجة العين</strong>، مثل<strong>: التهاب المفاصل الروماتويدي، ضمور فوكس</strong>، أو ما بعد عملية <strong>زراعة القرنية</strong>. قد يُسبب استخدام الكورتيكوستيرويدات ترققًا إضافيًّا ومن المحتمل أن يُؤدي إلى انثقاب، وقد يُؤخر التئام جرح العين لديك. من المعروف أيضًا أنَّ الأدوية المضادة للالتهابات غير الستيرويدية الموضعية تبطئ أو تؤخر الالتئام. يمكن أن يزيد الاستخدام المتزامن لمضادات الالتهاب غير الستيرويدية الموضعية مع الكورتيكوستيرويدات الموضعية احتمالية حدوث مشاكل بالالتئام.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من تفاعلات حساسية تجاه عقار توبرادكس، فتوقف عن استخدامه واستشر طبيبك. قد تتباين تفاعلات الحساسية من الحكة الموضعية أو احمرار الجلد إلى تفاعلات حساسية شديدة (التفاعل التَّأَقِيّ) أو تفاعلات جلدية خطيرة.&nbsp; قد تحدث تفاعلات الحساسية هذه مع المضادات الحيوية الموضعية أو الجهازية الأخرى من نفس المجموعة (الأمينوجليكوزيدات).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا تفاقمت الأعراض لديك أو عادت فجأة، فيُرجى استشارة طبيبك. قد تصبح أكثر عرضة لعدوى العين مع استخدام هذا المنتج.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يُرجى استشارة طبيبك إذا كنت تعاني من مرض السكري. يتزايد خطر ارتفاع الضغط داخل العين و/أو تكوين المياه البيضاء (كاتاراكت) النَّاجم عن استخدام الكورتيكوستيرويدات في مرضى السكري.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اتصل بطبيبك إذا أصبت بعدم وضوح الرؤية أو أية اضطرابات بصرية أخرى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تستخدم مضادات حيوية أخرى كعلاج، بما في ذلك المضادات الحيوية التي تُعطى عن طريق الفم، بالتَّزامن مع عقار توبرادكس، فاسأل طبيبك للنصيحة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني أو عانيت في السابق من حالات الوهن العضلي (ميسثينيا غريفيس) أو مرض الشلل الرعاش (باركنسون)، استشر طبيبك حيث أن المضادات من هذا النوع قد تؤدي لتفاقم الضعف العضلي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا استخدمت عقار توبرادكس لفترة زمنية طويلة، فقد تصبح أكثر عرضة للإصابة بعدوى العين، ارتفاع ضغط العين لديك أو تكوين المياه البيضاء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تحدَّث إلى طبيبك إذا أصبت بالتَّورم وزيادة الوزن حول الجذع وفي الوجه؛ حيث إنها عادة ما تكون أول أعراض&nbsp; لمتلازمة تُسمى&nbsp; متلازمة كوشينج. قد تصاب بكبت وظيفة الغدة الكظرية بعد وقف العلاج طويل الأمد أو المكثف بعقار توبرادكس. تحدَّث إلى طبيبك قبل إيقاف العلاج من تلقاء نفسك. تُعد هذه المخاطر ذات أهمية خاصَّة في الأطفال والمرضى ممن يتم علاجهم بعقار يُسمى ريتونافير أو كوبيسيستات.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تشمل علامات وأعراض كبت الغدة الكظرية: الإرهاق، شعورًا بخفة الرَّأس عند الوقوف أو صعوبة في الوقوف، ضعف العضلات، حمى، فقدان الوزن، القلق، الغثيان، القيء، إِسْهالًا، صداعًا، تعرُّقًا، تغيرات الحالة المزاجية أو الشخصية، وألمًا بالمفاصل والعضلات.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد لا يزال بإمكانك استخدام عقار توبرادكس، ولكن <strong>بعد مناقشة طبيبك</strong> أولًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وينبغي فحص الضَّغط داخل العين بصورة متكررة، وهذا مهم بشكل خاص في الأطفال دون 6 سنوات من العمر الذين يتلقون منتجات تحتوي على ديكساميثازون.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تعط عقار توبرادكس للأطفال الذين تقل أعمارهم عن عامين؛ نظرًا لأنَّه لم يثبت أمانه وفعاليته في هذه الشريحة من المرضى.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ج. التداخلات الدوائية من استعمال هذه المستحضر مع أدوية أخرى أو أعشاب أو مكملات غذائية</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>يُرجى إبلاغ الطبيب أو الصيدلي الخاص بك</strong> إذا كنت تستخدم أو استخدمت مؤخرًا أية أدوية أخرى، بما في ذلك الأدوية التي حصلت عليها دون وصفة طبية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أخبر طبيبك خاصَّةً إذا كنت تستخدم مضادات الالتهاب غير الستيرويدية الموضعية. يمكن للاستخدام المتزامن للستيرويدات الموضعية مع مضادات الالتهاب غير الستيرويدية الموضعية أن يزيد من حدوث مشكلات التئام القرنية. أخبر طبيبك إذا كنت تستخدم عقار ريتونافير أو كوبيسيستات؛ إذ قد يزيد هذا من كمية ديكساميثازون في الدَّم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كنت تستخدم <strong>قطرات أخرى للعين أو مراهم أخرى للعين، فانتظر لمدة 5 دقائق</strong> على الأقل بين كل دواء والآخر. يجب أن تكون مراهم العين آخر ما يتم استخدامه.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>د. الحمل والرضاعة </strong></p><p dir="RTL">إذا كنتِ حاملًا أو قد تصبحين حاملًا أو إذا كنت ترضعين طفلًا، <strong>تحدثي إلى طبيبك</strong> قبل استخدام عقار توبرادكس. لا يُوصى باستخدام عقار توبرادكس أثناء الحمل أو الرضاعة الطبيعيَّة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>و. تأثير عقار توبرادكس على القيادة واستخدام الآلات</strong></p><p dir="RTL">إذا تعرضت لعدم وضوح الرؤية بشكل مؤقت بعد استخدام عقار توبرادكس، فيجب أَلَّا تمارس القيادة أو تستخدم الآلات حتى تصبح الرؤية لديك واضحة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ز. معلومات هامَّة إذا كنت ترتدي عدسات لاصقة</strong></p><p dir="RTL">لا يُوصى بارتداء العدسات اللاصقة أثناء علاج عدوى أو التهاب بالعين. قد تُسبب مادة كلوريد البنزالكونيوم المستخدمة كمادة حافظة في عقار توبرادكس تهيج العين، وتغيُّر لون العدسات اللاصقة اللينة.</p><p dir="RTL">إذا كنت ترتدي <strong>عدسات لاصقة لينة</strong>، قم بإزالتها قبل استخدام عقار توبرادكس <strong>وانتظر لمدة 15 دقيقة على الأقل</strong> قبل وضعها مرة أخرى.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">استخدم دائمًا هذا الدَّواء كما أخبرك طبيبك بالضبط. يُرجى مراجعة الطبيب أو الصيدلي إذا لم تكن متأكدًا تمامًا من كيفية الاستخدام. لا تستخدم عقار توبرادكس إلا للتقطير داخل عينك (عينيك).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجرعة المعتادة</strong></p><p dir="RTL">الجرعة المعتادة هي قطرة واحدة في العين المُصابة/ العينين المصابتين كل 4 إلى 6 ساعات أثناء استيقاظك. أثناء الثمانية والأربعين ساعة الأولى، يمكن لطبيبك زيادة الجرعة&nbsp; إلى قطرة واحدة كل ساعتين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تستخدم هذا الدَّواء لمدة أكثر من<strong> 24 يومًا</strong>.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن استخدام عقار توبرادكس في الأطفال من سن سنتين فأكثر بنفس جرعة البالغين.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>قم بإزالة العنق غير المحكم</strong> من الغطاء عند فتح الزجاجة لأول مرة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">استخدم عقار توبرادكس دائمًا كما أخبرك طبيبك بالضبط.&nbsp; يجب مراجعة طبيبك أو الصيدلي إذا لم تكن متأكدًا من كيفية الاستخدام.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>كيفية الاستخدام</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اغسل يديك قبل البدء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>قم برَج الزجاجة جيدًا</strong>.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدر غطاء الزجاجة لنزعه.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أمسك الزجاجة بحيث يكون الطرف لأسفل، بين إبهامك وأصابعك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قم بإمالة رأسك إلى الخلف.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اجذب جفنك السفلي لأسفل بأحد أصابعك حتى يتكون &quot;جيب&quot; بين الجفن وعينك. ستدخل القطرة هنا (الصورة 1).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
 o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
 stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="Picture_x0020_1" o:spid="_x0000_i1025" type="#_x0000_t75"
 style='width:55.5pt;height:55.5pt;visibility:visible'>
 <v:imagedata src="file:///C:/Users/khalian2/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
  o:title=""/>
</v:shape><![endif]--><img width="74" height="74" alt="" src="file:///C:/Users/khalian2/AppData/Local/Temp/2/msohtmlclip1/01/clip_image002.jpg" /></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قَرِّب طرف الزجاجة من العين. قم بذلك أمام مرآة إذا كان هذا سيُساعدك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>لا تلمس عينك أو جفنك</strong> أو المناطق المحيطة بهما أو الأسطح الأخرى بالقطارة. فقد يلوث هذا القطرات.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>اضغط برفق على قاعدة الزجاجة</strong>؛ لتخرج قطرة واحدة في المرة الواحدة (الصورة 2).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><!--[if gte vml 1]><v:shape id="Picture_x0020_2" o:spid="_x0000_i1026"
 type="#_x0000_t75" style='width:55.5pt;height:55.5pt;visibility:visible'>
 <v:imagedata src="file:///C:/Users/khalian2/AppData/Local/Temp/2/msohtmlclip1/01/clip_image003.png"
  o:title=""/>
</v:shape><![endif]--><img width="74" height="74" alt="" src="file:///C:/Users/khalian2/AppData/Local/Temp/2/msohtmlclip1/01/clip_image004.jpg" /></p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>لا تضغط بقوة على الزجاجة</strong>، فقط تحتاج إلى الضغط برفق على الجزء السفلي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعد استخدام عقار توبرادكس، ابق جفنك مغلقًا، وفي الوقت نفسه اضغط بإصبعك برفق على زاوية العين المجاورة للأنف لمدة دقيقة واحدة على الأقل (الصورة 3). يُساعد هذا على الحد من كمية الدَّواء التي ستصل إلى باقي أجزاء الجسم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[if gte vml 1]><v:shape id="Picture_x0020_4" o:spid="_x0000_i1027"
 type="#_x0000_t75" style='width:55.5pt;height:56.25pt;visibility:visible'>
 <v:imagedata src="file:///C:/Users/khalian2/AppData/Local/Temp/2/msohtmlclip1/01/clip_image005.png"
  o:title=""/>
</v:shape><![endif]--><img width="84" height="74" alt="" src="file:///C:/Users/khalian2/AppData/Local/Temp/2/msohtmlclip1/01/clip_image006.gif" /></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تستخدم القطرات في كلا العينين، كرر الخطوات نفسها بالعين الأخرى. أغلق غطاء الزجاجة بإحكام بعد الاستخدام فورًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>إذا لم تدخل إحدى القطرات عينك</strong>، أعد المحاولة مرة أخرى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>إذا نسيت استعمال عقار توبرادكس</strong>، فلا داعي للقلق، فقط ضعه في أسرع وقت ممكن. <strong>لا تأخذ جرعة مضاعفة لتعويض الجرعات التي نسيتها</strong>.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>إذا استخدمت كمية أكثر مما يجب من عقار</strong> <strong>توبرادكس</strong>، يمكن شطفها من عينك بماء دافئ.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا كانت لديك أية أسئلة إضافية</strong> حول استخدام عقار توبرادكس، فاستشر طبيبك أو الصيدلي الخاص بك.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;</p><p dir="RTL">مثل كافة الأدوية، قد يُسبب عقار توبرادكس آثارًا جانبية، على الرَّغم من عدم حدوثها لدى الجميع.</p><p dir="RTL">لُوحظت الآثار الجانبية التَّالية مع عقار توبرادكس</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا لاحظت أيًّا من الآثار الجانبية المُحتمَلة التَّالية، <strong>فتوقف </strong>عن استخدام هذا الدَّواء واطلب المشورة الطبية العاجلة فورًا:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي مصحوب بحكة أو شرى (أرتكاريا).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم الوجه، الشفتين، اللسان أو أجزاء أخرى من الجسم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق النفس/ أزيز بالصدر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات جلدية شديدة مثل ظهور تقرحات والتي قد تكون مصحوبة بالتهاب الحلق، أو الحمّى أو الصداع.</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL">قد حدثت أيضًا الآثار الجانبية التَّالية مع عقار توبرادكس:</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الآثار الجانبيَّة غير الشَّائعة</strong></p><p dir="RTL"><em>(قد تُؤثر في ما يصل إلى شخص 1 من كل 100&nbsp;شخص)</em></p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><strong>التَّأثيرات في العين:</strong> ارتفاع الضغط داخل عينك (عينيك)، تهيُّج بالعين، ألم بالعين، حكة بالعين، عيون دامعة، وشعور بالانزعاج بالعين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية العامة:</strong> صداع، سيلان الأنف، ضيق الحلق.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الآثار الجانبيَّة النَّادرة</strong></p><p dir="RTL"><em>(قد تُؤثر في ما يصل إلى شخص 1 من كل 1000&nbsp;شخص) </em></p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><strong>التَّأثيرات في العين:</strong> احمرار، عدم وضوح الرؤية، جفاف العين، حساسية بالعين، التهاب سطح العين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية العامَّة:</strong> مذاق سيء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>غير معروفة </strong>(لا يمكن تقدير معدل التكرار من واقع البيانات المتاحة):</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><strong>التَّأثيرات في العين:</strong> زيادة في حجم حدقة العين، احمرار بجفن العين، تورم بجفن العين، زيادة إفراز الدُّموع.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية العامة:</strong> دوخة، غثيان، شعور بعدم الارتياح بالبطن، طفح جلدي، تورم بالوجه، حكة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;مشاكل بالهرمونات: نمو شعر الجسم بكثافة (خاصَّة في السيدات)، ضعف العضلات والهزال، علامات تمدد أرجوانية اللون على جلد الجسم، ارتفاع ضغط الدَّم، غياب دورات الحيض أو عدم انتظامها، تغيرات في مستويات البروتين والكالسيوم في جسمك، تضاؤل النمو في الأطفال والمراهقين وتورم وزيادة وزن الجسم والوجه (تُسمى &#39;متلازمة كوشينج&#39;) (انظر القسم 2: &quot;تحذيرات واحتياطات&quot;).</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا تم استخدام عقار توبرادكس لأكثر من 24 يومًا، فإنه قد يُسبب لك اكتساب عدوى ويمكن أيضًا أن يتأخر التئام الجرح الخاص بك.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ بعيدًا عن متناول ورؤية الأطفال.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يُحفَظ في درجة حرارة أقل من 30 درجة مئوية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تقم بتبريده أو تجميده.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ابق الزجاجة مغلقة بإحكام.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستعمل القطرات بعد انتهاء تاريخ الصَّلاحية المدون على الزجاجة والعبوة الكرتونية بعد كلمة &quot;EXP&quot;. يُشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>توقف عن استخدام الزجاجة بعد مرور أربعة أسابيع على فتحها لأول مرة</strong>؛ للوقاية من العدوى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب عدم التَّخلص من الأدوية عن طريق مياه الصرف أو مع المخالفات المنزلية.&nbsp; استشر الصيدلي الخاص بك عن كيفية التَّخلص من الأدوية التي لم تعد بحاجة إليها.&nbsp; ستُساعد هذه الإجراءات على حماية البيئة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>لا تعطِ هذا الدَّواء لآخرين</strong>، فقد يضر بهم، حتى إذا كانوا يعانون من نفس الأعراض التي تعاني أنت منها.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المواد الفعالة هي توبراميسين (3 مجم/ مللي لتر) وديكساميثازون (1 مجم/ مللي لتر).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الأخرى هي: إيديتات ثنائي الصوديوم، تيلوكسابول، كلوريد الصوديوم، كبريتيك الصوديوم، هيدروكسي إيثيل سليولوز، كلوريد البنزالكونيوم، حمض الكبريتيك و/أو هيدروكسيد الصوديوم (لضبط درجة الحموضة)، وماء مُنقى.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>عقار توبرادكس هو معلق ذو لون أبيض إلى أبيض مائل للاصفرار، متوفر في قنينة توزيع معتمة (قطارة دروبتينر) تحتوي على 5 مللي لتر.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مالك حق التسويق لهذا المنتج هي شركة نوفارتس فارما إيه جي.</p><p>www.Novartis.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم اعتماد هذه النشرة من قبل المملكة المتحدة في: أغسطس 2019م
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                TOBRADEX 3mg/ml/1mg/ml Eye Drops, Suspension
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each ml contains: Tobramycin 3mg Dexamethasone 1mg.
For full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Eye Drops, Suspension.
White to off-white suspension.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Prevention and treatment of inflammation and prevention of infection associated with cataract surgery in adults and children aged 2 years and older.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Adults:</u></p><p>One drop instilled into the conjunctival sac(s) every 4 to 6 hours while the patient is awake. &nbsp;During the initial 24 to 48 hours, the dosage may be increased to one drop every two hours while the patient is awake. Dosing should continue for 14 days not to exceed a maximum of 24 days.&nbsp; Frequency should be decreased gradually as warranted by improvement in clinical signs.&nbsp; Care should be taken not to discontinue therapy prematurely.</p><p>&nbsp;</p><p><u>Use in the Elderly:</u></p><p>Clinical studies have indicated dosage modifications are not required for use in the elderly.</p><p>&nbsp;</p><p><u>Paediatric population:</u></p><p>TOBRADEX may be used in children 2 years of age and older at the same dose as in adults. Currently available data is described in section 5.1.</p><p>&nbsp;</p><p>The safety and efficacy in children younger than 2 years of age have not been established, and no data is available.</p><p>&nbsp;</p><p><u>Use in hepatic and renal impairment:</u></p><p>TOBRADEX has not been studied in these patient populations</p><p>&nbsp;</p><p>Shake the bottle well before use.&nbsp; To prevent contamination of the dropper tip and suspension, care should be taken not to touch the eyelids, surrounding areas, or other surfaces with the dropper tip of the bottle.&nbsp; Keep the bottle tightly closed when not in use. After cap is removed, if tamper evident snap collar is loose, remove before using product.</p><p>&nbsp;</p><p>Gently closing the eyelid (s) and nasolacrimal occlusion for at least 1 minute after instillation is recommended. This may reduce the systemic absorption of medicinal products administered via the ocular route and result in a decrease in systemic side effects.</p><p>&nbsp;</p><p>In case of concomitant therapy with other topical ophthalmic medicinal products, an interval of 5 minutes should be allowed between successive applications.</p><p>&nbsp;</p><p>Eye ointments should be administered last.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                
•	Hypersensitivity to tobramycin or dexamethasone or to any of the excipients listed in section 6.1.
•		Herpes simplex keratitis.
•		Vaccinia, varicella and other viral disease of the cornea and conjunctiva .
•	Mycobacterial infections of the eye caused by, but not limited to, acid fast bacilli such as Mycobacterium tuberculosis, Mycobacterium leprae, or Mycobacterium avium. 
•		Fungal diseases of ocular structures or untreated parasitic eye infections. 
•		Untreated purulent infection of the eye. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>TOBRADEX is for topical use only and <strong>not</strong> for injection or oral use.&nbsp;</p><p>&nbsp;</p><p>Prolonged use of topical ophthalmic corticosteroids&nbsp; (i.e. longer than the maximum duration used in clinical trials [24 days]) may result in ocular hypertension/glaucoma with resultant damage to the optic nerve and reduced visual acuity and visual fields defects and may also result in posterior subcapsular cataract formation. &nbsp;</p><p>&nbsp;</p><p>Visual disturbance</p><p>Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids.</p><p>&nbsp;</p><p>It is advisable that the intraocular pressure be checked frequently. This is especially important in paediatric patients receiving dexamethasone-containing products, as the risk of steroid-induced ocular hypertension may be greater in children below 6 years of age and may occur earlier than a steroid response in adults. The frequency and duration of treatment should be carefully considered, and the intraocular pressure should be monitored from the outset of treatment, recognizing the risk for earlier and greater steroid-induced intraocular pressure increases in the paediatric patients.</p><p>&nbsp;</p><p>Cushing&rsquo;s syndrome and/or adrenal suppression associated with systemic absorption of ocular dexamethasone may occur after intensive or long-term continuous therapy in predisposed patients, including children and patients treated with CYP3A4 inhibitors (including ritonavir and cobicistat). In these cases, treatment should be progressively discontinued.</p><p>&nbsp;</p><p>The risk of corticosteroid-induced raised intraocular pressure and/or cataract formation is increased in predisposed patients (e.g. diabetes).</p><p>&nbsp;</p><p>Prolonged use may also result in secondary ocular infections due to suppression of host response.&nbsp; Corticosteroids may reduce resistance to and aid in the establishment of bacterial, viral, fungal or parasitic infections and mask the clinical signs of infection.&nbsp;</p><p>&nbsp;</p><p>Sensitivity to topically administered aminoglycosides may occur in some patients. Severity of hypersensitivity reactions may vary from local effects to generalized reactions such as erythema, itching, urticarial, skin rash, anaphylaxis, anaphylactoid reactions, or bullous reactions. If hypersensitivity develops during use of this medicine, treatment should be discontinued.</p><p>&nbsp;</p><p>Cross-hypersensitivity to other aminoglycosides can occur, and the possibility that patients who become sensitized to topical tobramycin may also be sensitive to other topical and/or systemic aminoglycosides should be considered.</p><p>&nbsp;</p><p>Serious adverse reactions including neurotoxicity, ototoxicity and nephrotoxicity have occurred in patients receiving systemic aminoglycoside therapy. Caution is advised when Tobradex eye drops are used concomitantly with systemic aminoglycosides.</p><p>&nbsp;</p><p>Caution should be exercised when prescribing Tobradex Eye Drops to patients with known or suspected neuromuscular disorders such as myasthenia gravis or Parkinson&rsquo;s disease. Aminoglycosides may aggravate muscle weakness because of their potential effect on neuromuscular function</p><p>Fungal infection should be suspected in patients with persistent corneal ulceration. If fungal infection occurs, corticosteroids therapy should be discontinued<strong>. </strong></p><p>&nbsp;</p><p>Prolonged use of antibiotics such as tobramycin may result in overgrowth of non-susceptible organisms, including fungi. If superinfection occurs, appropriate therapy should be initiated.</p><p>&nbsp;</p><p>Topical ophthalmic corticosteroids may slow corneal wound healing. Topical NSAIDs are also known to slow or delay healing. Concomitant use of topical NSAIDs and topical steroids may increase the potential for healing problems (see section 4.5).&nbsp;</p><p>&nbsp;</p><p>In those diseases causing thinning of the cornea or sclera, perforations have been known to occur with the use of topical corticosteroids.</p><p>&nbsp;</p><p>Benzalkonium chloride, used as a preservative in this product, has been reported to cause punctate keratopathy and/or toxic ulcerative keratopathy. Benzalkonium chloride may cause eye irritation and discolour soft contact lenses.&nbsp;</p><p>&nbsp;</p><p>Avoid contact with soft contact lenses. Contact lens wear is not recommended during treatment of an ocular infection or inflammation. If patients are allowed to wear contact lenses, they must be instructed to remove lenses prior to application of Tobradex and wait at least 15 minutes before reinsertion.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No clinically relevant interactions have been described with topical ocular dosing.</p><p>&nbsp;</p><p>Concomitant use of topical steroids and topical NSAIDs may increase the potential for corneal healing problems.</p><p>&nbsp;</p><p>Dexamethasone is metabolized via cytochrome P450 3A4 (CYP3A4). CYP3A4 inhibitors (including ritonavir and cobicistat); may decrease dexamethasone clearance resulting in increased effects and adrenal suppression/Cushing&rsquo;s syndrome. The combination should be avoided unless the benefit outweighs the increased risk of systemic corticosteroid side-effects, in which case patients should be monitored for systemic corticosteroid effects.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy:</u></p><p>&nbsp;</p><p>There are no or limited amount of data from the topical ocular use of tobramycin and dexamethasone in pregnant women. Tobramycin does cross the placenta into the fetus after intravenous dosing in pregnant women. Tobramycin is not expected to cause ototoxicity from in utero exposure. Prolonged or repeated corticoid use during pregnancy has been associated with an increased risk of intra-uterine growth retardation. Infants born of mothers who have received substantial doses of corticosteroids during pregnancy should be observed carefully for signs of hypoadrenalism.</p><p>&nbsp;</p><p>Studies in animals have shown reproductive toxicity after systemic administration of tobramycin and dexamethasone. These effects were observed at exposures considered sufficiently in excess of the maximum human ocular dosage delivered from the maternal use of the product (See section 5.3).</p><p>&nbsp;</p><p>TOBRADEX is not recommended during pregnancy.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>&nbsp;</p><p>Tobramycin is excreted in human milk after systemic administration. No data is available on the passage of dexamethasone into human breast milk. It is unknown whether tobramycin and dexamethasone are excreted in human milk following topical ocular administration. It is not likely that the amount of Tobramycin and Dexamethasone would be detectable in human milk or be capable of producing clinical effects in the infant following topical use of the product.</p><p>&nbsp;</p><p>A risk to the suckling child cannot be excluded. A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.</p><p>&nbsp;</p><p><u>Fertility</u></p><p>Studies have not been performed to evaluate the effect of tobramycin on human or animal fertility.<strong> </strong>There is limited clinical data to evaluate the effect of dexamethasone on male or female fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>TOBRADEX has no or negligible influence on the ability to drive and use machines.</p><p>No studies on the effects on the ability to drive and use machines have been performed. As with any eye drop, temporarily blurred vision or other visual disturbances may affect the ability to drive or use machines. If blurred vision occurs, the patient must wait until the vision is clear before driving or using machines.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Summary of the safety profile </u></p><p>In clinical studies involving over 1600 patients, TOBRADEX was administered up to six times daily. No serious ophthalmic or systemic adverse reactions related to TOBRADEX or components of the combination were reported in clinical studies. The most frequently reported adverse reactions with TOBRADEX were eye pain, intraocular pressure increased, eye irritation (burning upon instillation) and eye pruritus occurring in less than 1% of patients.</p><p>&nbsp;</p><p><u>Tabulated list of adverse reactions.</u></p><p>The following adverse reactions have been reported with TOBRADEX during clinical trials or during post marketing experience and are classified according to the subsequent convention: very common (&ge; 1/10), common (&ge;1/100 to &lt;1/10), uncommon (&ge;1/1,000 to &lt;1/100), rare (&ge;1/10,000 to &lt;1/1,000) and very rare (&lt;1/10,000), and not known (cannot be estimated from the available data).&nbsp; Within each frequency-grouping, adverse reactions are presented in order of decreasing seriousness.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:0px"><tbody><tr><td style="vertical-align:top"><p><strong>System organ classification</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Adverse reaction</strong></p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>anaphylactic reaction, hypersensitivity</p></td></tr><tr><td style="vertical-align:top"><p>Endocrine disorders</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Cushing&rsquo;s syndrome, adrenal suppression (see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Uncommon</p><p>&nbsp;</p><p>Not known</p></td><td style="vertical-align:top"><p>headache</p><p>&nbsp;</p><p>dizziness</p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>Uncommon</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Rare</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Not known</p></td><td style="vertical-align:top"><p>eye pain, eye pruritus, ocular discomfort, ocular hypertension, conjunctival oedema, increased intraocular pressure, eye irritation</p><p>&nbsp;</p><p>keratitis, eye allergy, vision blurred (see also section 4.4), dry eye, ocular hyperaemia</p><p>&nbsp;</p><p>eyelid oedema, erythema of the eyelid, mydriasis, lacrimation increased</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic, and mediastinal disorders</p></td><td style="vertical-align:top"><p>Uncommon</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>rhinorrhoea, laryngospasm</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Rare</p><p>&nbsp;</p><p>Not known</p></td><td style="vertical-align:top"><p>dysgeusia</p><p>&nbsp;</p><p>nausea, abdominal discomfort</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>erythema multiforme, rash, swelling face, pruritus</p></td></tr></tbody></table><p>&nbsp;</p><p><u>Description of selected adverse reactions</u></p><p>The following adverse reactions have been observed following use with Dexamethasone ophthalmic suspension:</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System organ classification</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Adverse reaction</strong></p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>headache</p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>eye irritation,* ocular hyperaemia,* erythema of eyelid, abnormal sensation in eye*</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic, and mediastinal disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>post nasal drip</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>The following adverse reactions have been observed following use with Tobramycin ophthalmic solution:</p><p><u>&nbsp;</u></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System organ classification</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Adverse reaction</strong></p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>Common</p><p>&nbsp;</p><p>Uncommon<strong> </strong></p></td><td style="vertical-align:top"><p>ocular hyperaemia,* eye pain*</p><p><strong>&nbsp;</strong></p><p>eye pruritus,* ocular discomfort,* eye allergy, eyelid oedema,* conjunctivitis,* glare, increased lacrimation,* keratitis*</p><p><strong>&nbsp;</strong></p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; These adverse reactions were also observed with TOBRADEX during post marketing.</p><p><strong>&nbsp;</strong></p><p>Prolonged use of topical ophthalmic corticosteroids may result in increased intraocular pressure with damage to the optic nerve, reduced visual acuity and visual field defects, posterior subcapsular cataract formation and delayed wound healing.</p><p>&nbsp;</p><p>Due to the corticosteroid component, in diseases causing thinning of the cornea or sclera there is a higher risk for perforation especially after long treatments (See Section 4.4).</p><p>&nbsp;</p><p>The development of secondary infection has occurred after the use of combinations containing corticosteroids and antimicrobials. Fungal infections of the cornea are particularly prone to develop coincidentally with long term applications of steroids.</p><p>&nbsp;</p><p>Serious adverse reactions including neurotoxicity, ototoxicity and nephrotoxicity have occurred in patients receiving systemic tobramycin therapy (See Section 4.4).</p><p>&nbsp;</p><p>Sensitivity to topically administered aminoglycosides may occur in some patients (See Section 4.4).</p><p>&nbsp;</p><p><u>To report any side effect(s):</u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Saudi Arabia</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Saudi Food and Drug Authority National Pharmacovigilance Center (NPC):</p><p>&nbsp;</p><p>o Fax: +966112057662</p><p>o Call NPC at +966-11-2038222, Exts: 2317-2356-2340.</p><p>o Toll free phone: 8002490000</p><p>o SFDA call center: 19999</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: https://ade.sfda.gov.sa</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patient Safety Department Novartis Consulting AG - Saudi Arabia:</p><p>&nbsp;</p><p>o Toll Free Number: 8001240078</p><p>o Phone: +966112658100</p><p>o Fax: +966112658107</p><p>o Email: adverse.events@novartis.com</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; Other GCC States:</p><p>-&nbsp; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Due to the characteristics of this preparation, no toxic effects are to be expected with an ocular overdose of this product, or in the event of accidental ingestion of the contents of one bottle or tube.</p><p>A topical overdose of TOBRADEX may be flushed from the eye(s) with lukewarm tap water.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group:&nbsp; Anti-inflammatory agents and anti-infectives in combination, corticosteroids and anti-infectives in combination.</p><p>ATC code:&nbsp; S01C A01.</p><p>&nbsp;</p><p><u>Dexamethasone:</u></p><p>The efficacy of corticosteroids for the treatment of inflammatory conditions of the eye is well established. Corticosteroids achieve their anti-inflammatory effects through suppression of vascular endothelial cell adhesion molecules, cyclooxygenase I or II, and cytokine expression. This action culminates in a reduced expression of pro-inflammatory mediators and the suppression of adhesion of circulating leukocytes to the vascular endothelium, thereby preventing their migration into inflamed ocular tissue. Dexamethasone has marked anti-inflammatory activity with reduced mineralocorticoid activity compared with some other steroids, and is one of the most potent anti-inflammatory agents.</p><p>&nbsp;</p><p><u>Tobramycin:</u></p><p>Tobramycin is a potent, broad-spectrum, rapidly bactericidal aminoglycoside antibiotic. It exerts its primary effect on bacterial cells by inhibiting polypeptide assembly and synthesis on the ribosome. Tobramycin in this combination provides antibacterial protection against susceptible bacteria.</p><p>&nbsp;</p><p>The following MIC breakpoints, separating susceptible from intermediate susceptible organisms, and intermediate susceptible from resistant organisms, are suggested: S&nbsp;(<u>&lt;</u> 4 mg/ml, R (<u>&gt;</u> 8 mg/ml). The prevalence of resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable. The following information gives only an approximate guidance on probabilities whether bacteria will be susceptible to tobramycin in TOBRADEX.</p><p>&nbsp;</p><p>The breakpoint definitions classifying isolates as susceptible or resistant are useful in predicting clinical efficacy of antibiotics that are administered systemically. However, when the antibiotic is administered in very high concentrations topically directly on the site of infection, these breakpoint definitions may not be applicable. Most isolates that would be classified as resistant by systemic breakpoints are indeed successfully treated topically.</p><p>&nbsp;</p><p><em>In&nbsp;vitro</em> studies have shown tobramycin to be active against most strains of common ocular pathogens and common skin flora bacteria as listed in the Table below:</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Categories</strong></p></td><td style="vertical-align:top"><p><strong>Frequency of Acquired Resistance in Europe</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>SENSITIVE SPECIES</strong></p><p><strong><em>Aerobic Gram-Positive Microorganisms</em></strong></p><p><em>Corynebacterium species</em></p><p><em>Staphylococcus aureus</em> Methicillin -S <sup>a</sup></p><p><em>Staphylococcus epidermidis</em>&nbsp; Methicillin -S <sup>a</sup></p><p>Other Coagulase-negative Staphylococci</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p><p>0-3%</p><p>0-3%</p><p>0-28%</p><p>0-40%</p></td></tr><tr><td style="vertical-align:top"><p><em>Aerobic Gram-Negative Microorganisms</em></p><p><em>Acinetobacter</em> <em>species</em></p><p><em>Citrobacter</em> <em>species</em></p><p><em>Escherichia coli</em></p><p><em>Enterobacter species</em></p><p><em>Haemophilus influenzae</em></p><p><em>Klebsiella species</em></p><p><em>Moraxella species</em></p><p><em>Proteus species</em></p><p><em>Pseudomonas aeruginosa</em></p><p><em>&nbsp;</em></p></td><td style="vertical-align:top"><p>&nbsp;</p><p>0%</p><p>0%</p><p>0%</p><p>0%</p><p>0%</p><p>0%</p><p>0%</p><p>0%</p><p>0%</p></td></tr><tr><td style="vertical-align:top"><p><strong><em>MODERATELY SUSCEPTIBLE SPECIES</em></strong></p><p><strong>(<em>in vitro,</em> intermediate susceptibility)</strong></p><p><em>Aerobic Gram-Negative Microorganisms</em></p><p><em>Serratia marcescens</em></p><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>INHERENTLY RESISTANT SPECIES</em></p><p><em>Aerobic Gram-Positive Microorganisms</em></p><p><em>Enterococcus species</em></p><p><em>Staphylococcus aureus </em>Methicillin &ndash;R <sup>a</sup></p><p><em>Staphylococcus epidermidis </em>Methicillin &ndash;R <sup>a</sup></p><p><em>Streptococcus pneumoniae</em></p><p><em>Streptococcus</em> <em>species</em></p><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>50 &ndash; 70%</p><p>30 &ndash; 40%</p></td></tr><tr><td style="vertical-align:top"><p><em>Aerobic Gram-Negative Microorganisms</em></p><p><em>Burkholderia cepacia</em></p><p><em>Stenotrophomonas maltophilia</em></p><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>Anaerobic microorganisms</em></p><p>Strict anaerobic bacteria<br />&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>Others</em><br /><em>Chlamydia species<br />Mycoplasma species<br />Rickettsia species</em><br />&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p><sup>a&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </sup>Methicillin-susceptible (S), Methicillin-resistant (R). The beta-lactam (i.e., methicillin; penicillin) resistance phenotype is unrelated to the aminoglycoside resistance phenotype and both are unrelated to the virulence phenotypes. Some methicillin-resistant (R) S. aureus strains (MRSA) are susceptible to tobramycin (MIC: S <u>&lt;</u>4); conversely some strains of methicillin&ndash;susceptible (S) S. aureus (MSSA) are resistant to tobramycin (MIC: S <u>&gt;</u>8)</p><p>&nbsp;</p><p>The frequency of methicillin resistance (R) may be up to 50 % of all staphylococci in some European countries.</p><p>&nbsp;</p><p><u>Paediatric Population</u></p><p>&nbsp;</p><p>The safety and efficacy of TOBRADEX in children have been established by broad clinical experience, but only limited data are available. In a clinical study of TOBRADEX suspension for the treatment of bacterial conjunctivitis, 29 paediatric patients, ranging in age from 1 to 17 years, were treated with 1 or 2 drops of TOBRADEX every 4 or 6 hours for 5 or 7 days. In this study, differences in the safety profile between adult and paediatric patients were not observed.</p><p>&nbsp;</p><p><em>Other information</em></p><p>Cross-resistance between aminoglycosides (e.g., gentamicin and tobramycin) is due to the specificity of the enzyme modifications, Adenyltransferase (ANT) and Acetyltransferase (ACC). However, cross-resistance varies between the aminoglycoside antibiotics due to the differing specificity of the various modifying enzymes. The most common mechanism of acquired resistance to aminoglycosides is antibiotic inactivation by plasmid and transposon-encoded modifying enzymes.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tobramycin:</p><p>Animal studies have shown that tobramycin is absorbed into the cornea following ocular administration. Following systemic administration to patients with normal renal function, a plasma half-life of approximately 2 hours has been observed. Tobramycin is eliminated almost exclusively by glomerular filtration with little if any biotransformation. Plasma concentrations of tobramycin following the 2-day topical ocular regimen of TOBRADEX were below the limit of quantification in most subjects or low (&pound;0.25 microgram/ml).</p><p>&nbsp;</p><p>Dexamethasone:</p><p>Following ocular administration, dexamethasone is absorbed into the eye with maximum concentrations in the cornea and aqueous humour attained within 1-2 hours. The plasma half-life of dexamethasone is approximately 3 hours. Dexamethasone is eliminated extensively as metabolites. Systemic exposure to dexamethasone is low following topical ocular administration of TOBRADEX. Peak dexamethasone plasma levels after the last topical dose ranged from 220 to 888pg/ml (mean 555 &plusmn; 217pg/ml) after administration of one drop of TOBRADEX to each eye four times per day for two consecutive days.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data revealed no special hazard for humans from topical ocular exposure to tobramycin or dexamethasone based on conventional repeated-dose topical ocular toxicity studies, genotoxicity or carcinogenicity studies. Effects in non-clinical reproductive and developmental studies with tobramycin and dexamethasone were observed only at exposures considered sufficiently in excess of the maximum human ocular dosage indicating little relevance to clinical use for low-dose short-term courses of therapy.</p><p>&nbsp;</p><p>Tobramycin has not been shown to induce teratogenicity in rats or rabbits. The ocular administration of 0.1% dexamethasone resulted in fetal anomalies in rabbits. Dexamethasone had no adverse effects on female fertility in a chorionic gonadotropin primed rat model.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Disodium edetate</p><p>Hydroxyethylcellulose</p><p>Benzalkonium chloride</p><p>Purified water</p><p>Sodium chloride</p><p>Sodium sulphate anhydrous</p><p>Sulphuric acid for pH adjustment and / or</p><p>Sodium hydroxide for pH adjustment</p><p>Tyloxapol</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.

After the first opening of the container, the sterile ophthalmic suspension should not be used longer than four weeks.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store below 30⁰C.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not refrigerate or freeze.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>5ml dropper container (LDPE) and screw cap (polypropylene).</p><p>Pack size: 1x5ml.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The Marketing Authorization Holder for this Product is Novartis Pharma AG. 
www.Novartis.com 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                13 August 2019 by MHRA.
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>